Significant cellular sensitivity to peripheral nerve antigens was found by MIF assay in 36% of patients with lung cancer (P<0·005) as compared with 62% of patients with peripheral neuropathy without neoplasia. No sensitivity was found in controls or the cancer sub-group without neuromuscular abnormality. The significance of these findings for an immune mechanism is discussed.
Statistics from Altmetric.com
An electrophysiological and immunological study of patients with carcinoma of the lung
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.